AXON insider files to sell 10,000 shares via UBS for $7.44M

Rhea-AI Filing Summary

Axon Enterprise, Inc. insider notice reports a proposed sale of 10,000 common shares through UBS Financial Services on Nasdaq with an aggregate market value of $7,436,415, dated for sale on 09/08/2025. The same block of 10,000 shares was acquired by option exercise on 11/15/2021 and paid in cash on that date. The filer also reported a prior sale of 10,000 common shares by Patrick W. Smith on 08/11/2025 for $8,312,887 in gross proceeds. The filing omits the issuer's address and the filing individual's CIK/CCC details.

Positive

• Acquisition method disclosed: The 10,000 shares were acquired by option exercise on 11/15/2021 and paid in cash, providing clear provenance for the securities.
• Broker and market disclosed: Sale is routed through UBS Financial Services on Nasdaq, indicating an organized market execution plan.

Negative

• Large insider sale proposed: A high-value block of $7,436,415 is planned for sale, which may be viewed negatively by some investors due to size.
• Missing filer/issuer identifiers: The filing omits the issuer name and filer CIK/CCC, limiting transparency and preventing easy cross-reference with other disclosures.

Insights

Securities Analyst

TL;DR: Insider plans to sell a large, high-value block of 10,000 AXON shares previously acquired by option exercise.

The notice documents a proposed sale of 10,000 common shares valued at $7.44 million via UBS on Nasdaq for 09/08/2025. The shares were obtained by option exercise on 11/15/2021 and paid in cash, which is a routine insider disposition method. A separate sale of 10,000 shares on 08/11/2025 produced $8.31 million gross proceeds, indicating recent material insider liquidity. Without issuer-level context (outstanding share percentage, insider role), market-impact assessment is limited; however, the transactions are notable for size and timing.

Corporate Governance Expert

TL;DR: The filing is a standard Rule 144 notice showing lawful disposition of previously acquired shares but lacks identifying filer details.

The document correctly discloses that 10,000 shares to be sold were acquired via option exercise and paid for in cash on 11/15/2021. It includes broker details (UBS) and a planned sale date. The filing contains a representation about absence of undisclosed material information and references Rule 10b5-1 language, consistent with compliance practice. Missing filer identifiers (CIK/CCC) and the issuer name reduce transparency for stakeholder review.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. Eleven Madison Avenue 4th Floor New York NY 10010	10000	7436415.00	78504440	09/08/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/15/2021	Option Exercise	Issuer			10000	11/15/2021	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Patrick W. Smith 17800 N. 85TH ST. Scottsdale AZ 85255	Common	08/11/2025	10000	8312887.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What is being reported in this Form 144 for AXON?

The notice reports a proposed sale of 10,000 common shares on 09/08/2025 through UBS on Nasdaq with an aggregate market value of $7,436,415.

How were the shares being sold acquired?

The 10,000 shares were acquired by option exercise on 11/15/2021 and payment was made in cash on that date.

Has the filer sold any AXON shares recently?

Yes. The filing discloses a prior sale of 10,000 shares by Patrick W. Smith on 08/11/2025 for $8,312,887 in gross proceeds.

Through which broker will the proposed sale be executed?

The sale is planned to be executed through UBS Financial Services, Inc. (Eleven Madison Avenue, New York) on Nasdaq.

Does the filing indicate any undisclosed material information?

By signature, the person selling represents they do not know any material adverse information about the issuer that has not been publicly disclosed.

Are there any missing details in this Form 144?

Yes. The filing does not provide the issuer's name in the issuer section and omits filer identifiers such as CIK/CCC in the visible content.